![Dawn Bell](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Dawn Bell
Direktor/Vorstandsmitglied bei STRM.Bio, Inc.
Profil
Dawn Bell is currently working as a Director at STRM.Bio, Inc. She obtained a doctorate degree from the University of Florida.
Aktive Positionen von Dawn Bell
Unternehmen | Position | Beginn |
---|---|---|
STRM.Bio, Inc.
![]() STRM.Bio, Inc. BiotechnologyHealth Technology STRM.Bio, Inc. is a pre-clinical biotechnology company based in Cambridge, MA. The company's goal is to make gene therapy safe for repeat dosing and to provide a future of medicine for patients with rare diseases worldwide. The company, which was founded by Jonathan Thon and has had him as CEO since incorporation, is backed by venture capital and focuses on developing and delivering targeted gene therapies using extracellular vesicles. | Direktor/Vorstandsmitglied | 17.05.2023 |
Ausbildung von Dawn Bell
University of Florida | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
STRM.Bio, Inc.
![]() STRM.Bio, Inc. BiotechnologyHealth Technology STRM.Bio, Inc. is a pre-clinical biotechnology company based in Cambridge, MA. The company's goal is to make gene therapy safe for repeat dosing and to provide a future of medicine for patients with rare diseases worldwide. The company, which was founded by Jonathan Thon and has had him as CEO since incorporation, is backed by venture capital and focuses on developing and delivering targeted gene therapies using extracellular vesicles. | Health Technology |